MD/PhD student at @VanderbiltMSTP | ophthalmology, glaucoma, neurodegeneration, glia | @VanderbiltU 2017 | he/him | Views are my own
Joined May 2021
- Tweets40
- Following156
- Followers185
- Likes398
Pinned Tweet
I’m excited to share my first first-authored paper from my #PhD work, out now in @FrontiersIn Cellular Neuroscience! We explored intrinsic properties of retinal ganglion cells which may contribute to their different responses in #vision: frontiersin.org/articles/10.…
Andrew Boal retweeted
Join us Tues 3/28 at 10am in 214 LH for Andrew Boal's @EyeBoal Dissertation Defense "Retinal Ganglion Cell Excitability and Adaptations to Ionic Stress in Glaucomatous Optic Neuropathy" completed in Dr. David Calkins lab in the Neuro Grad Program @VanderbiltBrain and @VUMCEye!
ALT Smiling man with glasses, brown hair, blue button up collard shirt, standing in from of a blurred background of green trees.
Honored to receive notice that my F30 is being funded by the @NatEyeInstitute! I’m grateful for the support I’ve received from @VanderbiltMSTP and @VanderbiltBrain and excited to continue exploring the interaction of astrocytes and retinal ganglion cells in #glaucoma. #mdphd
ALT Notice of award for F30 from the National Eye Institute
We found that sensitivity to potassium underlies differing excitability and action potential shapes in aON-S and aOFF-S RGCs. Interestingly, elevating potassium concentration shifts the responses of aON-S cells to resemble those of aOFF-S at baseline.
These findings may offer insight into key physiologic differences that cause some RGCs to degenerate more quickly than others in #glaucoma and lay the groundwork for future targets for #neuroprotection
This was such a wonderful opportunity! I really enjoyed getting to share some of our work in front of many of my science idols
So proud of @EyeBoal who last-minute subbed in for Michael Risner @iserworld @_BrightFocus this afternoon! Andrew talked about human RGCs cultured in multiple conditions and how the morphology of their axon initial segments changes depending on their environment 🧫👀🐭🧠
Grateful to have the support of @_BrightFocus and @iserworld to present my research and learn from some of the best in the #glaucoma field! This meeting is a wonderful learning opportunity for a young scientist. Come see me at poster #5 tonight!
👏 Please join us in congratulating these @_BrightFocus and @iserworld travel grantees!
We are honored to invest in these awardees’ continued success in vision #research.
Thank you to our sponsors for making these awards possible.
#GlaucomaFastTrack
ALT BrightFocus/ISER Travel Grantees
Excited to present my work this afternoon! Come find me at #ARVO2022 and chat about RGC physiology
This Post is from an account that no longer exists. Learn more
Great to see my lab mate present his exciting work at #ARVO2022 !
This Post is from an account that no longer exists. Learn more
Andrew Boal retweeted
You can officially call me Dr. Naguib now!!! Today I successfully defended my PhD in neuroscience after 4 years of hard work. I am so unbelievably thrilled to be done #PhDone #PhinallyDone
I’m looking forward to hosting the trivia night to cap off this excellent conference we have planned! Come for the science, mentorship, and networking opportunities #doubledocs #mdphd
It's true! Our next #MDPhD meeting is happening soon! Join us from anywhere for a day full of #science, interactive breakout sessions, and making connections! Registration ($5) is open now, full schedule here: southeasternmdphd.org/agenda
Missed my intended cell and accidentally patched this handsome retinal astrocyte #HappyLittleAccidents #Glia #doubledocs
Andrew Boal retweeted
It was an honor to write this with (and learn so much from) my co-mentors @LisaMonteggia and Dr. Ege Kavalali!
A key takeaway: the timing and location of BDNF action is critical in its downstream effects, which can be multiple and contradictory
Our latest work attempts to resolve BDNF in context:from synaptic regulation to psychiatric disorders. #neurotrophin #bdnf #depression #bipolardisorder sciencedirect.com/science/ar…
Andrew Boal retweeted
"This is my body, I have to defend it!" 🏠
Reminder: Being vaccinated and boosted is your best line of defense against severe illness from COVID-19.
Subscribe to our newsletter for the latest info: publichealth.jhu.edu/headlin…
Andrew Boal retweeted
Grateful to have received a booster shot @VUMChealth. Sad that I had the opportunity to get a third shot while folks in my country have not had access to their first. Hard to feel anything but intense anger towards those who have that opportunity but don't take advantage of it.
💉 6.4 billion COVID vaccine doses have been administered
👥 46% of world population with at least 1 dose
🌍 Share with at least 1 dose
High-income countries: 69%
Upper-middle income: 64%
Lower-middle income: 32%
Low income: 2%
Our data on vaccinations: ourworldindata.org/covid-vac…
Andrew Boal retweeted
Every Wednesday our entire program gets together for seminar! Today G3 @EyeBoal gave a chalk talk to Edwards-Goodpasture about his research on glaucoma!
ALT Andrew is wearing a mask and a blue shirt. He is standing by a whiteboard on which he has drawn some of the pathophysiology of glaucoma.
A wonderful opportunity to work with @AlexSilverMSTP is available!
Translational #CancerResearch postdoc position open in the Savona lab! Project involves studying the #hematopoietic niche with primary patient samples in ex vivo #organoids.
Full description here: nature.com/naturecareers/job…
Lab Website:
medsites.vumc.org/savonalab/…
Please RT!
MD/PhD training is a long and difficult road, but it helps to have a great group of friends doing it alongside you! Check out this article where our class reflects on memories from our first 4 years as friends @VanderbiltMSTP medschool.vanderbilt.edu/mst…
#doubledocs #mdphd
Andrew Boal retweeted
New review from @EyeBoal (G3) out now in @MDPIOpenAccess Cells! This review covers how #astrocyte networks (not just individual cells) are involved in diseases like #glaucoma, and how these networks might be targeted therapeutically (open access): mdpi.com/2073-4409/10/6/1368…
